arrow
J

Jolanta Krajewska

Silesian University of Technology
H指数:28
被引数:2,729

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TERT promoter variants in risk stratification of Polish patients with papillary thyroid carcinoma

波兰乳头状甲状腺癌患者风险分层中的TERT启动子变异

2026-04-290
PRE
OC14 - Brain metastasis in differentiated thyroid cancer: an international multicentric retrospective analysis

OC14 - 分化型甲状腺癌脑转移:一项国际多中心回顾性分析

2025-09-220
OA
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer

患者报告的Selpercatinib耐受性对比卡博赞尼/Vandetanib:一项针对RET突变髓样甲状腺癌的LIBRETTO-531随机对照试验的二次分析

Thyroid
IF6.7
2025-08-180
PRE
Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy – Item GP5

评估副作用困扰、负担和耐受性:一项探索癌症治疗功能评估量表GP5条目内容有效性的定性研究

2025-07-040
OA
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-RefractoryDifferentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study
THYROID
IF6.7
2024-03-015
OAAI
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

一项随机、双盲、非劣效性研究,旨在评估卡博替尼片剂每日60毫克与卡博替尼胶囊每日140毫克在进展性转移性甲状腺髓样癌患者中的疗效。

THYROID
IF6.7
2022-05-0110
OAAI
Thyroid nodules with indeterminate cytopathology: a constant challenge in everyday practice. The effectiveness of clinical decisions using diagnostic tools available in Poland

细胞病理学检查结果不确定的甲状腺结节:日常临床实践中的持续挑战。在波兰可用的诊断工具支持下的临床决策的有效性

2021-10-114
OA
Therapeutic Strategy in Low-Risk Papillary Thyroid Carcinoma - Long-Term Results of the First Single-Center Prospective Non-Randomized Trial Between 2011 and 2015

低危甲状腺乳头状癌的治疗策略-2011和2015之间的第一个单中心前瞻性非随机试验的长期结果

2021-09-064
OAAI
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey
2020-07-1011
OAAI
Heterogeneity of Thyroid Cancer

甲状腺癌的异质性

2018-02-06142
OAAI
Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations (vol 7, 42074, 2017)
2017-03-151
OAAI
Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations
2017-02-0925
OAAI